Patent: 3,973,002
✉ Email this page to a colleague
Summary for Patent: 3,973,002
| Title: | Antihemophilic factor |
| Abstract: | A quick-dissolving antihemophilic factor preparation is obtained by adjusting the pH of buffer-extracted plasma cryoprecipitate to from about pH 6 to about pH 7.0 and cooling to a temperature of from about 2.degree.C to about 20.degree.C for from about 15 minutes to about 1 hour, in order to precipitate certain protein impurities, primarily fibrinogen. |
| Inventor(s): | Hagan; James J. (Holmdel, NJ), Glaser; Charles (Raritan, NJ) |
| Assignee: | E. R. Squibb & Sons, Inc. (Princeton, NJ) |
| Application Number: | 05/573,684 |
| Patent Claims: | see list of patent claims |
Details for Patent 3,973,002
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Grifols Therapeutics Llc | KOATE, KOATE-DVI | antihemophilic factor (human) | For Injection | 101130 | January 24, 1974 | 3,973,002 | 1995-05-01 |
| Takeda Pharmaceuticals U.s.a., Inc. | HEMOFIL M | antihemophilic factor (human) | For Injection | 101448 | March 14, 2001 | 3,973,002 | 1995-05-01 |
| Csl Behring Llc | MONOCLATE, MONOCLATE-P | antihemophilic factor (human) | For Injection | 103953 | May 14, 2003 | 3,973,002 | 1995-05-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
